[1]刘华,崔秀卿,邢金梅,等.银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死临床观察[J].西部中医药,2021,34(07):98-101.[doi:10.12174/j.issn.2096-9600.2021.07.25]
　LIU Hua,CUI Xiuqing,XING Jinmei,et al.Clinical Observation on Ginkgo Leaf Extract and Dipyridamole Injection, Butylphthalide and Reteplase in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2021,34(07):98-101.[doi:10.12174/j.issn.2096-9600.2021.07.25]
点击复制

银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死临床观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年07期
页码:
98-101
栏目:
衷中参西
出版日期:
2021-07-15

文章信息/Info

Title:
Clinical Observation on Ginkgo Leaf Extract and Dipyridamole Injection, Butylphthalide and Reteplase in Treating Acute Cerebral Infarction
作者:
刘华1, 崔秀卿2, 邢金梅2, 时岩2
1.安国市医院，河北 保定 071200
2.保定市第二医院
Author(s):
LIU Hua1, CUI Xiuqing2, XING Jinmei2, SHI Yan2
1.Anguo City Hospital, Baoding 071200, China
2.Baoding City the Second Hospital
关键词:
急性脑梗死; 1型纤维蛋白溶解酶原激活抑制剂; 超氧化物歧化酶; 血浆组织纤维蛋白溶解酶原激活剂; 神经功能; 生活质量; 银杏达莫; 丁苯酞; 瑞替普酶
Keywords:
acute cerebral infarction; PAI-1; SOD; t-PA; neurological function; quality of life; ginkgo leaf extract and dipyridamole injection; butylphthalide; reteplase
分类号:
R512.62
DOI:
10.12174/j.issn.2096-9600.2021.07.25
摘要:
目的观察银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死的临床疗效。 方法将急性脑梗死患者120例采用随机数字表法分为两组各60例，对照组采用丁苯酞联合瑞替普酶治疗，治疗组在对照组基础上加用银杏达莫治疗，7天为1个疗程，两个疗程后观察两组患者临床疗效，检测治疗前后两组患者血清C反应蛋白（C-reaction protein，CRP）、肿瘤坏死因子α（tumor necrosis factor α，TNF-α）、白细胞介素1β（interleukin-1β，IL-1β）、超氧化物歧化酶（superoxide dismutase，SOD）、丙二醛（malonaldehyde，MDA）、一氧化氮（nitric oxide，NO），血浆组织纤维蛋白溶解酶原激活剂（tissue-type plaminogen activator，t-PA）、1型纤维蛋白溶解酶原激活抑制剂（plasminogen activator inhibitor-1，PAI-1）水平，评估两组患者神经功能缺损评分（national institute of health stroke scale，NIHSS）及日常生活能力评分（activities of daily living，ADL）。 结果总有效率治疗组为91.7%（55/60），优于对照组的83.3%（50/60），差异有统计学意义（P＜0.05）。两组治疗后CRP、TNF-α、IL-1β、MDA、PAI-1水平及NIHSS评分较治疗前降低，SOD、NO、t-PA水平及ADL评分较治疗前升高，治疗组各项指标改善程度优于对照组，差异均有统计学意义（P＜0.05）。 结论银杏达莫联合丁苯酞及瑞替普酶能减轻急性脑梗死患者炎症反应，调节血浆纤维蛋白溶解系统功能，清除体内氧自由基及提高抗氧化酶活性，能恢复患者的神经功能，提高其日常生活能力，改善患者生活质量，效果优于丁苯酞联合瑞替普酶。
Abstract:
ObjectiveTo observe clinical effects of ginkgo leaf extract and dipyridamole injection, butylphthalide and reteplase in treating acute cerebral infarction(ACI). MethodsAll 120 patients were allocated to two groups according to random number table method, 60 cases each group, the control group were treated by butylphthalide and reteplase, the treatment group by ginkgo leaf extract and dipyridamole injection based on the therapty the control group accepted, seven days were one course, to observe clinical effects in both groups after two courses, to detect the levels of CRP, TNF-α, IL-1β, SOD, MDA, NO, t-PA and PAI-1 before and after treating between both groups, to assess NIHSS scores and ADL scores between both groups. ResultsTotal effective rate of the treatment group was 91.7%(55/60), superior to 83.3%(50/60) of the control group, and the difference had statistical meaning (P＜0.05). The levels of CRP, TNF-α, IL-1β, MDA, PAI-1 and NIHSS scores of both groups after treating reduced than before treating, the levels of SOD, NO and t-PA and ADL scores rose compared with these before treating, and the improvements of different indexes of the treatment group were superior to these of the control group, and the difference had statistical meaning (P＜0.05). ConclusionGinkgo leaf extract and dipyridamole injection, butylphthalide and reteplase could relieve inflammatory reaction in ACI patients, regulate the function of plasma fibrinolysis system, eliminate oxygen free radicals in vivo and enhance the activity of antioxidant enzyme, help the recovery of neurological function, lift ADL, improve quality of life in patients, and its effects superior to these of butylphthalide and reteplase.

相似文献/References:

[1]曹骅,张振昶.银杏二萜内酯葡胺注射液治疗急性脑梗死疗效观察[J].西部中医药,2019,32(03):74.
　CAO Hua,ZHANG Zhenchang.Clinical Observation on Treating Acute Cerebral Infarction with Ginkgo Biloba Diterpene Lactone Meglumine Injection[J].Western Journal of Traditional Chinese Medicine,2019,32(07):74.
[2]蓝雪花,陈嘉汇,覃丽容,等.中医护理在急性脑梗死患者中的应用[J].西部中医药,2019,32(08):126.
　LAN Xuehua,CHEN Jiahui,QIN Lirong,et al.The Application of TCM Nursing to the Patients Suffering Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2019,32(07):126.
[3]苏韫,牛明慧,成新平,等.马铃薯糖苷生物碱对化疗性静脉炎兔t-PA、PAI-1及兔耳注射部位温度的影响[J].西部中医药,2020,33(01):25.[doi:10.12174/j.issn.1004-6852.2020.01.07]
　SU Yun,NIU Minghui,CHENG Xinping,et al.Influence of Potato Saccharide Alkaloids on t-PA, PAI-1 and the Temperature of Rabbit Ear Injection Site of Rabbit with Chemotherapy-induced Phlebitis[J].Western Journal of Traditional Chinese Medicine,2020,33(07):25.[doi:10.12174/j.issn.1004-6852.2020.01.07]
[4]杨光,岳扬,才蕊.银杏叶提取物注射液联合持续正压通气治疗急性脑梗死合并OSAHS 43例[J].西部中医药,2020,33(04):99.[doi:10.12174/j.issn.1004-6852.2020.04.30]
　YANG Guang,YUE Yang,CAI Rui.Ginkgo Biloba Leaf Extract Injection Joined with Continuous Positive Airway Pressure in Treating 43 Cases of Acute Cerebral Infarction Complicated with OSAHS[J].Western Journal of Traditional Chinese Medicine,2020,33(07):99.[doi:10.12174/j.issn.1004-6852.2020.04.30]
[5]刘华,崔秀卿,邢金梅,等.银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死临床观察[J].西部中医药,2020,33(S1):90.
　LIU Hua,CUI Xiuqing,XING Jinmei,et al.Clinical Observation on Ginkgo Leaf Extract and Dipyridamole Injection,Butylphthalide and Reteplase in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2020,33(07):90.
[6]赵琴.通痹活络汤联合依达拉奉对急性脑梗死患者血清CXCL-16、MCP-1和GDF-15的影响[J].西部中医药,2022,35(01):16.[doi:10.12174/j.issn.2096-9600.2022.01.04]
　ZHAO Qin.Effects of Tongbi Huoluo Decoction Combined with Edaravone on Serum CXCL-16, MCP-1 and GDF-15 in Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2022,35(07):16.[doi:10.12174/j.issn.2096-9600.2022.01.04]
[7]秦保锋,王明哲,龚帆,等.地黄饮子加减对急性脑梗死患者血小板聚集率及VEGF的影响[J].西部中医药,2021,34(01):95.[doi:10.12174/j.issn.2096-9600.2021.01.25]
　QIN Baofeng,WANG Mingzhe,GONG Fan,et al.Effects of Modified Dihuang Yingzi on Platelet Aggregation Rate and VEGF in the Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2021,34(07):95.[doi:10.12174/j.issn.2096-9600.2021.01.25]

备注/Memo

备注/Memo:
刘华（1984—），女，主治医师。研究方向：脑血管病的中西医结合防治。保定市科技计划项目（18ZF016）。
更新日期/Last Update: 2021-07-15